title: Helpful hints in caring for patients receiving biotherapy. Rigors associated with outpatient tumor necrosis factor administration.
authors: Mayo Clinic, Rochester, MN.
authors: L
authors: L
authors: Hanson
authors: J
authors: J
authors: Hermanson
authors: J
authors: J
authors: Lee
authors: J
authors: J
authors: Nickelson
authors: R
authors: R
authors: Sloan
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D008545:Melanoma / Q000628:therapy*; D008614:Meperidine / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced* / Q000517:prevention & control; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014409:Tumor Necrosis Factor-alpha; D008614:Meperidine